Literature DB >> 18415022

A molecular mechanism of P-loop pliability of Rho-kinase investigated by molecular dynamic simulation.

Keigo Gohda1, Toshio Hakoshima.   

Abstract

Rho-kinase is a leading player in the regulation of cytoskeletal events involving smooth muscle contraction and neurite growth-cone collapse and retraction, and is a promising drug target in the treatment of both vascular and neurological disorders. Recent crystal structure of Rho-kinase complexed with a small-molecule inhibitor fasudil has revealed structural details of the ATP-binding site, which represents the target site for the inhibitor, and showed that the conserved phenylalanine on the P-loop occupies the pocket, resulting in an increase of protein-ligand contacts. Thus, the P-loop pliability is considered to play an important role in inhibitor binding affinity and specificity. In this study, we carried out a molecular dynamic simulation for Rho-kinase-fasudil complexes with two different P-loop conformations, i.e., the extended and folded conformations, in order to understand the P-loop pliability and dynamics at atomic level. A PKA-fasudil complex was also used for comparison. In the MD simulation, the flip-flop movement of the P-loop conformation starting either from the extended or folded conformation was not able to be observed. However, a significant conformational change in a long loop region covering over the P-loop, and also alteration of ionic interaction-manner of fasudil with acidic residues in the ATP binding site were shown only in the Rho-kinase-fasudil complex with the extended P-loop conformation, while Rho-kinase with the folded P-loop conformation and PKA complexes did not show large fluctuations, suggesting that the Rho-kinase-fasudil complex with the extended P-loop conformation represents a meta-stable state. The information of the P-loop pliability at atomic level obtained in this study could provide valuable clues to designing potent and/or selective inhibitors for Rho-kinase.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18415022     DOI: 10.1007/s10822-008-9214-7

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  22 in total

Review 1.  H-series protein kinase inhibitors and potential clinical applications.

Authors:  N Ono-Saito; I Niki; H Hidaka
Journal:  Pharmacol Ther       Date:  1999 May-Jun       Impact factor: 12.310

Review 2.  Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells.

Authors:  K Kaibuchi; S Kuroda; M Amano
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 3.  Rocks: multifunctional kinases in cell behaviour.

Authors:  Kirsi Riento; Anne J Ridley
Journal:  Nat Rev Mol Cell Biol       Date:  2003-06       Impact factor: 94.444

4.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

Review 5.  Protein kinase inhibitors: insights into drug design from structure.

Authors:  Martin E M Noble; Jane A Endicott; Louise N Johnson
Journal:  Science       Date:  2004-03-19       Impact factor: 47.728

Review 6.  Rho kinase, a promising drug target for neurological disorders.

Authors:  Bernhard K Mueller; Helmut Mack; Nicole Teusch
Journal:  Nat Rev Drug Discov       Date:  2005-05       Impact factor: 84.694

7.  New-generation amber united-atom force field.

Authors:  Lijiang Yang; Chun-Hu Tan; Meng-Juei Hsieh; Junmei Wang; Yong Duan; Piotr Cieplak; James Caldwell; Peter A Kollman; Ray Luo
Journal:  J Phys Chem B       Date:  2006-07-06       Impact factor: 2.991

8.  The mechanism of inhibition of the cyclin-dependent kinase-2 as revealed by the molecular dynamics study on the complex CDK2 with the peptide substrate HHASPRK.

Authors:  Iveta Bártová; Michal Otyepka; Zdenek Kríz; Jaroslav Koca
Journal:  Protein Sci       Date:  2005-01-04       Impact factor: 6.725

9.  Protein kinase A in complex with Rho-kinase inhibitors Y-27632, Fasudil, and H-1152P: structural basis of selectivity.

Authors:  Christine Breitenlechner; Michael Gassel; Hiroyoshi Hidaka; Volker Kinzel; Robert Huber; Richard A Engh; Dirk Bossemeyer
Journal:  Structure       Date:  2003-12       Impact factor: 5.006

10.  A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes.

Authors:  T Leung; E Manser; L Tan; L Lim
Journal:  J Biol Chem       Date:  1995-12-08       Impact factor: 5.157

View more
  1 in total

1.  Elaborate ligand-based modeling reveal new submicromolar Rho kinase inhibitors.

Authors:  Rand Shahin; Saja Alqtaishat; Mutasem O Taha
Journal:  J Comput Aided Mol Des       Date:  2011-12-14       Impact factor: 3.686

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.